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Niemann–Pick disease type C (NPC) is a lysosomal storage disorder, an 
autosomal recessive disease with an estimated incidence of 1 : 150,000, 
caused by mutations in the NPC1 or NPC2 proteins . The disease manifests 
in ataxia, seizures, and early dementia, and is typically fatal. In addition to 
aberrant trafficking of cholesterol, the levels and cellular distribution pattern 
of α-tocopherol are abnormal in brains and livers of NPC mouse models. 
Currently, there is no cure for NPC and all established therapies are for relief 
of symptoms with limited efficacy. Clinical trials with Miglustat are in progress 
with favorable preliminary results.Moreover, the ‘trapped’ α-tocopherol is not 
available for cellular use, and thought to contribute to the increased oxidative 
stress observed in NPC models , and likely underlie the anatomic and functional 
decline of the cerebellum seen in NPC . The notion that defective vitamin E 
status is an important factor in NPC disease is supported by studies showing that 
vitamin E( δ-tocopherol) supplementation improves cognitive function in mouse 
models of NPC disease with reducing the accumulation of free cholesterols and 
reduction of the size of enlarged lysosomes. 
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